NICE U-turn on Forxiga
May 30, 2013Sales and Marketing Forxiga, NICE
NICE has recommended Bristol-Myers Squibb and AstraZeneca’s diabetes drug Forxiga in final draft guidance after turning its back on the …
SCM Pharma appoints new director
May 30, 2013Manufacturing and Production, Research and Development, Sales and Marketing SCM Pharma
UK-based contract development and manufacturing organisation SCM Pharma has strengthened its senior management team by recruiting a director. Paul Bradley …
New HIV pill for UK
May 29, 2013Sales and Marketing Gilead, HIV, stribild
Gilead Sciences has launched Stribild, a once-daily single tablet regimen to combat HIV – the virus which causes AIDS – …
Amgen moves into Japanese market with Astellas deal
May 29, 2013Sales and Marketing Amgen, Astellas, Vectibix, Zhejiang
Amgen and Astellas have announced a new collaboration that will see them launch five new medicines in Japan from 2016, …
Diovan trials may have been run by Novartis staff
May 29, 2013Research and Development, Sales and Marketing Diovan, Novartis
Several post-marketing clinical trials of the blockbuster blood pressure drug Diovan may have been run by employees of the drug’s …
Valeant to buy B+L for $8.7 billion
May 29, 2013Sales and Marketing B+L, Valeant
Canadian firm Valeant Pharmaceuticals International is to buy Bausch + Lomb in an $8.7 billion deal which will see the …
Xarelto gets ACS indication
May 29, 2013Sales and Marketing ACS, Bayer, Xarelto
Bayer HealthCare’s bloodthinner Xarelto has expanded its reach in Europe with approval for secondary prevention after an acute coronary syndrome …
FDA rejects Valeant’s efinaconazole on packaging grounds
May 29, 2013Manufacturing and Production FDA, Valeant
Valeant Pharmaceuticals has had its application to market antifungal candidate efinaconazole turned down by the FDA because of issues related …
Pharmaniaga joins push into MENA with Saudi JV
May 29, 2013Manufacturing and Production MENA, Pharmaniaga, Saudi
Malaysian drugmaker Pharmaniaga has formed a joint venture in Saudi Arabia as it starts a push into the fast-growing Middle …
Grant NICE greater trial data access – report
May 29, 2013Research and Development, Sales and Marketing Goldacre, NICE, transparency, trials
A new report by the National Audit Office says NICE should be given greater powers to access clinical trial data. …
Wireless pill bottle wins Boehringer challenge
May 29, 2013Medical Communications Boehringer, brett wells, wireless
Developers of a pill bottle that wirelessly measures medication and sends patient reminders have emerged as prize-winners in a Healthcare …
Orphan drug for Astellas
May 29, 2013Sales and Marketing Astellas, Isavuconazole, Orphan
The FDA has granted orphan designation to one of Astellas’ Phase III drugs designed to treat potentially life-threatening fungal infections …
FDA experts recommend Merck sleep pill
May 24, 2013Research and Development, Sales and Marketing FDA, Merck, insomnia, suvorexant
Merck received welcome news this week from the FDA after one of the US regulator’s expert groups voted to approve …
Janssen outlines pipeline ambitions
May 24, 2013Research and Development, Sales and Marketing Janssen, Johnson and Johnson, pipeline
Janssen has outlined plans to submit ‘more than ten’ new product filings worldwide in the next four years, along with …
Hurel appoints Schering-Plough executive to its Board
May 24, 2013Manufacturing and Production, Research and Development, Sales and Marketing Hurel, Merck, Schering-Plough
Pre-clinical products firm Hurel has appointed Dr James MacDonald to the company’s Board of directors. MacDonald is the former executive …
Boehringer held up by FDA for production violations
May 24, 2013Manufacturing and Production API, Boehringer, FDA
Boehringer Ingelheim has pledged to resolve manufacturing compliance issues at a facility in Germany uncovered by the US Food and …
GSK to cull Australian tablet packaging plant
May 23, 2013Manufacturing and Production Australia, GSK
A GlaxoSmithKline tablet packaging facility in Australia will be closed with the loss of 120 jobs, around a third of …
Positive news for Sanofi asthma drug
May 23, 2013Sales and Marketing Dupilumab, Regeneron, Sanofi, asthma
An asthma drug being developed by Sanofi and Regeneron Pharmaceuticals has performed well in a Phase IIa trial, reducing the …
Nicholson to step down as NHS leader
May 23, 2013Sales and Marketing Francis report, Mid Staffs, NHS, Nicholson
Sir David Nicholson is to retire from his post as chief executive of NHS England in March 2014.Sir David has …
GSK gets $200m from White House
May 23, 2013Research and Development, Sales and Marketing AMR, BARDA, GSK, HHS, white house
GlaxoSmithKline is to be given up to $200 million by the US government to develop new antibiotics as worries grow …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
